Fig. 1From: Interpreting the efficacy enhancement mechanism of Chinese medicine processing from a biopharmaceutic perspectiveHydrolysis reaction of flavonoid glycoside components during processing. A Epimedin A is hydrolyzed into sagittatoside A; B Epimedin B is hydrolyzed into sagittatoside B; C Epimedin C is hydrolyzed into 2″-O-rhamnosylicariside II; D 3‴-carbonyl-2″-β-l-quinovosyl icariin is hydrolyzed into icariin; E liquiritin apioside is hydrolyzed into liquiritigenin; F isoliquiritin apioside is hydrolyzed into isoliquiritigeninBack to article page